Portfolio company
Cortexyme
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops small-molecule therapeutics targeting bacterial pathogens to treat neurodegenerative diseases and rare skeletal conditions for patients with high unmet clinical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cognition Therapeutics
This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.
Yumanity Therapeutics
This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.
Athira Pharma
This biopharmaceutical company develops small molecule therapies for patients with neurodegenerative conditions and certain cancers.
AMYL THERAPEUTICS
The company develops pan-amyloid immunotherapies to treat patients with neurodegenerative and rare diseases caused by toxic protein aggregates.
Sortina
This company develops small molecule therapeutics targeting sortilin to treat cancer and neurodegenerative diseases for patients with unmet medical needs.
Rodin Therapeutics
This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.
Asceneuron
The company develops oral small molecule therapies for neurodegenerative diseases including Alzheimer's and Parkinson's to treat patients suffering from chronic neurologic disorders.
